These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 22921696)

  • 21. Metabolic risk factors in pediatric and adult calcium oxalate urinary stone formers: is there any difference?
    Tefekli A; Esen T; Ziylan O; Erol B; Armagan A; Ander H; Akinci M
    Urol Int; 2003; 70(4):273-7. PubMed ID: 12740490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High dietary magnesium intake decreases hyperoxaluria in patients with nephrolithiasis.
    Eisner BH; Sheth S; Dretler SP; Herrick B; Pais VM
    Urology; 2012 Oct; 80(4):780-3. PubMed ID: 22921695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Identification of lithogenic risk factors by a simplified first-line laboratory assessment in urinary calculi patients].
    Glémain P; Prunet D
    Prog Urol; 2006 Nov; 16(5):542-5. PubMed ID: 17175947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Impact of Dietary Modifications and Medical Management on 24-Hour Urinary Metabolic Profiles and the Status of Renal Stone Disease in Recurrent Stone Formers.
    Abu-Ghanem Y; Kleinmann N; Erlich T; Winkler HZ; Zilberman DE
    Isr Med Assoc J; 2021 Jan; 23(1):12-16. PubMed ID: 33443336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of obesity in patients with urolithiasis and its prognostic usefulness in stone recurrence.
    Lee SC; Kim YJ; Kim TH; Yun SJ; Lee NK; Kim WJ
    J Urol; 2008 Feb; 179(2):570-4. PubMed ID: 18078957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients.
    Ekeruo WO; Tan YH; Young MD; Dahm P; Maloney ME; Mathias BJ; Albala DM; Preminger GM
    J Urol; 2004 Jul; 172(1):159-63. PubMed ID: 15201761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of dietary interventions on 24-hour urine parameters in patients with idiopathic recurrent calcium oxalate stones.
    Kıraç M; Küpeli B; Irkilata L; Gülbahar O; Aksakal N; Karaoğlan U; Bozkırlı I
    Kaohsiung J Med Sci; 2013 Feb; 29(2):88-92. PubMed ID: 23347810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetic kidney stone formers excrete more oxalate and have lower urine pH than nondiabetic stone formers.
    Eisner BH; Porten SP; Bechis SK; Stoller ML
    J Urol; 2010 Jun; 183(6):2244-8. PubMed ID: 20400141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The risk of recurrent urolithiasis in children is dependent on urinary calcium and citrate.
    DeFoor WR; Jackson E; Minevich E; Caillat A; Reddy P; Sheldon C; Asplin J
    Urology; 2010 Jul; 76(1):242-5. PubMed ID: 20110113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The urinary response to an oral oxalate load in recurrent calcium stone formers.
    Krishnamurthy MS; Hruska KA; Chandhoke PS
    J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypertension is associated with increased urinary calcium excretion in patients with nephrolithiasis.
    Eisner BH; Porten SP; Bechis SK; Stoller ML
    J Urol; 2010 Feb; 183(2):576-9. PubMed ID: 20018328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and metabolic abnormalities of vitamin D-inadequate patients presenting with urolithiasis to a tertiary stone clinic.
    Elkoushy MA; Sabbagh R; Unikowsky B; Andonian S
    Urology; 2012 Apr; 79(4):781-5. PubMed ID: 22035763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Sodium excretion in children with lithogenic disorders].
    Kovacević L; Kovacević S; Smoljanić Z; Peco-Antić A; Kostić N; Gajić M; Kovacević N; Jovanović O
    Srp Arh Celok Lek; 1998; 126(9-10):321-6. PubMed ID: 9863402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stone forming risk factors in patients with type Ia glycogen storage disease.
    Scales CD; Chandrashekar AS; Robinson MR; Cantor DA; Sullivan J; Haleblian GE; Leitao VA; Sur RL; Borawski KM; Koeberl D; Kishnani PS; Preminger GM
    J Urol; 2010 Mar; 183(3):1022-5. PubMed ID: 20092831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contributory metabolic factors in the development of nephrolithiasis in patients with medullary sponge kidney.
    Yagisawa T; Kobayashi C; Hayashi T; Yoshida A; Toma H
    Am J Kidney Dis; 2001 Jun; 37(6):1140-3. PubMed ID: 11382681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adequacy of a single 24-hour urine collection for metabolic evaluation of recurrent nephrolithiasis.
    Castle SM; Cooperberg MR; Sadetsky N; Eisner BH; Stoller ML
    J Urol; 2010 Aug; 184(2):579-83. PubMed ID: 20639021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A multiregional Italian cohort of 24-hour urine metabolic evaluation in renal stone formers.
    Esperto F; Marangella M; Trinchieri A; Petrarulo M; Miano R
    Minerva Urol Nefrol; 2018 Feb; 70(1):87-94. PubMed ID: 28882031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urinary stone formers with hypocitraturia and 'normal' urinary pH are at high risk for recurrence.
    Strohmaier WL; Seilnacht J; Schubert G
    Urol Int; 2012; 88(3):294-7. PubMed ID: 22398801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study of Urine Composition of Patients With Recurrent Nephrolithiasis in Lorestan, Iran.
    Hadian B; Zafar-Mohtashami A; Ghorbani F
    Iran J Kidney Dis; 2018 Jan; 12(1):22-26. PubMed ID: 29421773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium-to-Citrate Ratio Distinguishes Solitary and Recurrent Urinary Stone Forming Children.
    DeFoor W; Jackson E; Schulte M; Alam Z; Asplin J
    J Urol; 2017 Aug; 198(2):416-421. PubMed ID: 28365270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.